July 20, 2023
Snapshot Top 10: Dow Jones U.S. Pharmaceuticals Index
The Top 10 performing stocks in the Dow Jones U.S. Pharmaceuticals Index are shown for seven different investment strategies. Whether you are looking for value, growth or dividend stocks, or you want stocks that rank well overall, you can see the top 10 stock picks, together with how they rank on a scale of 1 to 100 from the perspective of different investment strategies. We have also added our newest Sentiment and 360° View ranks, which encapsulate the market voices of analysts and professional investors into a simple ranking for easily evaluating stocks. As an objective research provider, Obermatt has been refining its stock analysis algorithms for more than 10 years (no AI used here!)
Select any stock for the detailed analysis of that stock's performance across the different investment analyses. Please note that the Top 10 stocks focus only on Large to XX-Large companies.
What the six ranks mean
For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".
Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".
Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.
Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.
(NEW ) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).
(NEW ) 360° View - the ultimate rating with all financial and non-financial indicators.
Special Analysis: TOP 10 Dividend Investment Strategy
Many people ask for tips about dividend stocks. These are the Top 10 dividend stocks in the Dow Jones U.S. Pharmaceuticals Index as of July 20, 2023.
TOP 10 Dividend Investment Strategy
DIVIDEND
VALUE
COMBINED
360° VIEW
1. Pfizer (XXL, US) Pharmaceuticals
1. Pfizer (XXL, US) Pharmaceuticals
100
98
75
58
2. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
98
94
70
49
3. Phibro Animal (L, US) Pharmaceuticals
3. Phibro Animal (L, US) Pharmaceuticals
98
100
95
83
4. Johnson & Johnson (XXL, US) Pharmaceuticals
4. Johnson & Johnson (XXL, US) Pharmaceuticals
96
63
49
31
5. Merck & Co. (XXL, US) Pharmaceuticals
5. Merck & Co. (XXL, US) Pharmaceuticals
94
55
65
60
6. Eli Lilly (XXL, US) Pharmaceuticals
6. Eli Lilly (XXL, US) Pharmaceuticals
85
23
35
74
7. Zoetis (XL, US) Pharmaceuticals
7. Zoetis (XL, US) Pharmaceuticals
85
23
16
49
☀ This company has a special achievement which is documented on its stock research page.
July 20, 2023. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Obermatt 360° Investment Strategy
TOP 10 Obermatt 360° Investment Strategy
360° VIEW
VALUE
COMBINED
SENTIMENT
1. Assertio Therapeutics (S, US) Pharmaceuticals
1. Assertio Therapeutics (S, US) Pharmaceuticals
93
73
96
67
2. Amphastar (M, US) Pharmaceuticals
2. Amphastar (M, US) Pharmaceuticals
89
4
79
86
3. Heska (S, US) Health Care Equipment
3. Heska (S, US) Health Care Equipment
88
40
55
46
4. Phibro Animal (L, US) Pharmaceuticals
4. Phibro Animal (L, US) Pharmaceuticals
83
100
95
18
5. Prestige (L, US) Pharmaceuticals
5. Prestige (L, US) Pharmaceuticals
76
49
44
96
6. Eli Lilly (XXL, US) Pharmaceuticals
6. Eli Lilly (XXL, US) Pharmaceuticals
74
23
35
90
7. Pacira BioSciences (M, US) Pharmaceuticals
7. Pacira BioSciences (M, US) Pharmaceuticals
70
45
44
78
8. Merck & Co. (XXL, US) Pharmaceuticals
8. Merck & Co. (XXL, US) Pharmaceuticals
60
55
65
60
9. Pfizer (XXL, US) Pharmaceuticals
9. Pfizer (XXL, US) Pharmaceuticals
58
98
75
40
10. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
10. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
49
94
70
42
July 20, 2023. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Sentiment Investment Strategy
TOP 10 Sentiment Investment Strategy
SENTIMENT
VALUE
COMBINED
360° VIEW
1. Zoetis (XL, US) Pharmaceuticals
1. Zoetis (XL, US) Pharmaceuticals
96
23
16
49
2. Prestige (L, US) Pharmaceuticals
2. Prestige (L, US) Pharmaceuticals
96
49
44
76
3. Eli Lilly (XXL, US) Pharmaceuticals
3. Eli Lilly (XXL, US) Pharmaceuticals
90
23
35
74
4. Amphastar (M, US) Pharmaceuticals
4. Amphastar (M, US) Pharmaceuticals
86
4
79
89
5. Pacira BioSciences (M, US) Pharmaceuticals
5. Pacira BioSciences (M, US) Pharmaceuticals
78
45
44
70
6. Assertio Therapeutics (S, US) Pharmaceuticals
6. Assertio Therapeutics (S, US) Pharmaceuticals
67
73
96
93
7. Merck & Co. (XXL, US) Pharmaceuticals
7. Merck & Co. (XXL, US) Pharmaceuticals
60
55
65
60
8. Supernus Pharma (M, US) Pharmaceuticals
8. Supernus Pharma (M, US) Pharmaceuticals
54
16
14
18
9. Heska (S, US) Health Care Equipment
9. Heska (S, US) Health Care Equipment
46
40
55
88
10. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
10. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
42
94
70
49
July 20, 2023. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Value Investment Strategy
TOP 10 Value Investment Strategy
VALUE
GROWTH
COMBINED
360° VIEW
1. Phibro Animal (L, US) Pharmaceuticals
1. Phibro Animal (L, US) Pharmaceuticals
100
35
95
83
2. Pfizer (XXL, US) Pharmaceuticals
2. Pfizer (XXL, US) Pharmaceuticals
98
11
75
58
3. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
94
41
70
49
4. Nektar (S, US) Pharmaceuticals
4. Nektar (S, US) Pharmaceuticals
78
5
69
28
5. Assertio Therapeutics (S, US) Pharmaceuticals
5. Assertio Therapeutics (S, US) Pharmaceuticals
73
67
96
93
6. Johnson & Johnson (XXL, US) Pharmaceuticals
6. Johnson & Johnson (XXL, US) Pharmaceuticals
63
25
49
31
7. Merck & Co. (XXL, US) Pharmaceuticals
7. Merck & Co. (XXL, US) Pharmaceuticals
55
63
65
60
8. Prestige (L, US) Pharmaceuticals
8. Prestige (L, US) Pharmaceuticals
49
57
44
76
9. Pacira BioSciences (M, US) Pharmaceuticals
9. Pacira BioSciences (M, US) Pharmaceuticals
45
47
44
70
10. Heska (S, US) Health Care Equipment
10. Heska (S, US) Health Care Equipment
40
31
55
88
July 20, 2023. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Growth Investment Strategy
TOP 10 Growth Investment Strategy
GROWTH
VALUE
COMBINED
360° VIEW
1. Eli Lilly (XXL, US) Pharmaceuticals
1. Eli Lilly (XXL, US) Pharmaceuticals
91
23
35
74
2. Amphastar (M, US) Pharmaceuticals
2. Amphastar (M, US) Pharmaceuticals
91
4
79
89
3. Assertio Therapeutics (S, US) Pharmaceuticals
3. Assertio Therapeutics (S, US) Pharmaceuticals
67
73
96
93
4. Merck & Co. (XXL, US) Pharmaceuticals
4. Merck & Co. (XXL, US) Pharmaceuticals
63
55
65
60
5. Prestige (L, US) Pharmaceuticals
5. Prestige (L, US) Pharmaceuticals
57
49
44
76
6. Zoetis (XL, US) Pharmaceuticals
6. Zoetis (XL, US) Pharmaceuticals
55
23
16
49
7. Pacira BioSciences (M, US) Pharmaceuticals
7. Pacira BioSciences (M, US) Pharmaceuticals
47
45
44
70
8. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
8. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
41
94
70
49
9. Phibro Animal (L, US) Pharmaceuticals
9. Phibro Animal (L, US) Pharmaceuticals
35
100
95
83
10. Heska (S, US) Health Care Equipment
10. Heska (S, US) Health Care Equipment
31
40
55
88
July 20, 2023. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Safety Investment Strategy
TOP 10 Safety Investment Strategy
SAFETY
VALUE
COMBINED
360° VIEW
1. Nektar (S, US) Pharmaceuticals
1. Nektar (S, US) Pharmaceuticals
91
78
69
28
2. Amphastar (M, US) Pharmaceuticals
2. Amphastar (M, US) Pharmaceuticals
91
4
79
89
3. Assertio Therapeutics (S, US) Pharmaceuticals
3. Assertio Therapeutics (S, US) Pharmaceuticals
87
73
96
93
4. Phibro Animal (L, US) Pharmaceuticals
4. Phibro Animal (L, US) Pharmaceuticals
82
100
95
83
5. Heska (S, US) Health Care Equipment
5. Heska (S, US) Health Care Equipment
79
40
55
88
6. Pfizer (XXL, US) Pharmaceuticals
6. Pfizer (XXL, US) Pharmaceuticals
76
98
75
58
7. Supernus Pharma (M, US) Pharmaceuticals
7. Supernus Pharma (M, US) Pharmaceuticals
73
16
14
18
8. Johnson & Johnson (XXL, US) Pharmaceuticals
8. Johnson & Johnson (XXL, US) Pharmaceuticals
64
63
49
31
9. Pacira BioSciences (M, US) Pharmaceuticals
9. Pacira BioSciences (M, US) Pharmaceuticals
58
45
44
70
10. Merck & Co. (XXL, US) Pharmaceuticals
10. Merck & Co. (XXL, US) Pharmaceuticals
49
55
65
60
July 20, 2023. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Combined Investment Strategy
TOP 10 Combined Investment Strategy
COMBINED
VALUE
GROWTH
360° VIEW
1. Assertio Therapeutics (S, US) Pharmaceuticals
1. Assertio Therapeutics (S, US) Pharmaceuticals
96
73
67
93
2. Phibro Animal (L, US) Pharmaceuticals
2. Phibro Animal (L, US) Pharmaceuticals
95
100
35
83
3. Amphastar (M, US) Pharmaceuticals
3. Amphastar (M, US) Pharmaceuticals
79
4
91
89
4. Pfizer (XXL, US) Pharmaceuticals
4. Pfizer (XXL, US) Pharmaceuticals
75
98
11
58
5. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
5. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
70
94
41
49
6. Nektar (S, US) Pharmaceuticals
6. Nektar (S, US) Pharmaceuticals
69
78
5
28
7. Merck & Co. (XXL, US) Pharmaceuticals
7. Merck & Co. (XXL, US) Pharmaceuticals
65
55
63
60
8. Heska (S, US) Health Care Equipment
8. Heska (S, US) Health Care Equipment
55
40
31
88
9. Johnson & Johnson (XXL, US) Pharmaceuticals
9. Johnson & Johnson (XXL, US) Pharmaceuticals
49
63
25
31
10. Prestige (L, US) Pharmaceuticals
10. Prestige (L, US) Pharmaceuticals
44
49
57
76
July 20, 2023. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
☀ This company has a special achievement which is documented on its stock research page.
Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards .
Top 10 Stocks from the purely fact-based Obermatt Method in the stock index Dow Jones U.S. Pharmaceuticals Index from July 20, 2023.
Top 10 Stock History D.J. US Pharmaceutical
Select Top 10 Date
Jul‑2023
Dec‑2022
Apr‑2022
Aug‑2020
Mar‑2020
Oct‑2019
Apr‑2019
Nov‑2018
Jun‑2018
Oct‑2017
Apr‑2017
Jan‑2017
Jan‑2016
Jan‑2015
Obermatt Portfolio Performance We’re so convinced about our research, that we buy our stock tips. See the performance of the Obermatt portfolio .